zfu@hindujahospital.com


Welcome to Dr Zarir F Udwadia's Website



Dr Zarir F Udwadia is a consultant chest physician at the Hinduja Hospital, Breach Candy Hospital and Parsee General Hospitals. He is an MD, DNB, FRCP (London.), and FCCP (USA). A post-graduate of the Grant Medical College, Bombay, he has spent 5 years training in various centers of excellence in the U.K including the prestigious Brompton Hospital, London. On his return he established an active chest department at the Hinduja Hospital. This includes Bombay's busiest bronchoscopy and PFT services and the city's first sleep laboratory. More


Special Mention


A) The only Indian doctor to be invited by WHO, Geneva to be part of a core task force to formulate new TB treatment guidelines for 2009 at a meeting held in Paris in 2008 October.
B) Dr Zarir Udwadia and team are the first to describe Totally Drug Resistant TB (TDR-TB) from India. This attracts intense media and scientific attention with coverage by all the National dailies and BBC, Science, Nature, Wall Street Journal, CNN, and Lancet coverage.


Principles of Respiratory Medicine



Principles of Respiratory Medicine is a book by Dr. Zarir Udwadia which is recently published by Oxford International Press. This is the first international textbook of respiratory medicine that gives an Indian perspective of common respiratory problems.


Photographer: Lauren Rudser

Articles by Dr Udwadia

1. Totally drug resistant tuberculosis in India. Clinical Infectious Diseases. 2012;54:579-581.

2. Prevalence of venous thromboembolism in acute exacerbations of chronic obstructive pulmonary disease: an Indian perspective. Indian J Chest Dis Allied Sci 2011:53(4): 207-210.

3. Primary immune deficiency in the intensive care unit: it's never too late to diagnose and treat. Indian J Crit Care Med. 2011:15(3): 179-181.

4. Safety and efficacy of thioridazine as salvage therapy in Indian patients with XDR-TB. Recent Pat Antiinfect Drug Discovery. 2011:6(2): 88-91.

1. Private patient perceptions about a public programme: what do private Indian tuberculosis patients really feel about directly observed treatment? BMC Public Health. 2010 Jun 22; 10(1): 357.

2. Tuberculosis management by private practitioners in Mumbai, India: has anything changed in two decades. PLoS ONE Aug 2010. Vol 5: Issue 8: e12023

3. Tumor necrosis alpha-blocker induced tuberculosis. J Rheumatol 2010: 37::7: 1542.

4. Evaluation of light emitting diode-based fluorescence microscopy for the detection of mycobacteria in a tuberculosis-endemic region. Int J Tuberc Lung Dis 2011. 15(4): 483-488.

5. Universal access for MDR-TB limited without the involvement of the private sector. Int J Tuberc Lung Dis. 2011

6. Safety and efficacy of thioridazine as salvage therapy in Indian patients with XDR-TB. Recent Pat Antiinfect Drug Discovery. 2011. 1:6; (2): 88-91.

7. Retrospective study of ILD in a tertiary care center in India. Indian J Chest Disease Allied Science. 2010; 52: 191-193.

8. Why 'STOP TB' is incomplete without quit smoking. Indian J Chest Dis Allied Sci. 2011; 53: 9-10.

9. Statins and the lung: hope or hype? Indian J Chest Dis Allied Sci. 2011

10. Assessment of linezolid efficacy and safety in MDR- and XDR-TB: an Indian perspective.

Click to view more articles by Dr Udwadia

Query Me

  *
  *
  *